Expression of PCAT6 has also been shown to be altered in NSCLC [50,51], and circulating levels of this lncRNA in patient blood has potential as both a diagnostic and prognostic biomarker in NSCLC [51]. This evidence concerns the gene PCAT6 and non-small cell lung carcinoma.